Dendritic cells as programmable platforms for cancer immunotherapy.

Liu Y, Marcandalli E, Liu Y, Bayerl F, Pittet MJ, De Palma M

DOI: 10.1016/j.it.2026.08.013
Published: 2026 Sep 16
Container: Trends in immunology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.it.2026.08.013,
  title = {Dendritic cells as programmable platforms for cancer immunotherapy.},
  author = {Liu Y and Marcandalli E and Liu Y and Bayerl F and Pittet MJ and De Palma M},
  year = {2026},
  journal = {Trends in immunology},
  doi = {10.1016/j.it.2026.08.013},
  url = {https://doi.org/10.1016/j.it.2026.08.013}
}

RIS

TY  - JOUR
TI  - Dendritic cells as programmable platforms for cancer immunotherapy.
AU  - Liu Y
AU  - Marcandalli E
AU  - Liu Y
AU  - Bayerl F
AU  - Pittet MJ
AU  - De Palma M
PY  - 2026
JO  - Trends in immunology
DO  - 10.1016/j.it.2026.08.013
UR  - https://doi.org/10.1016/j.it.2026.08.013
ER  -

APA

Y, L., E, M., Y, L., F, B., MJ, P., & M, D. P. (2026). Dendritic cells as programmable platforms for cancer immunotherapy.. Trends in immunology. https://doi.org/10.1016/j.it.2026.08.013

Source records

pubmed · retrieved 2026-09-25T00:10:44.290Z